Investigating COVID-19 in hospitalized children in Norway
Official title: COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology
Run by University Hospital, Akershus · NCT04335773 · Data updated 2026-11-12
This study looks at how COVID-19 affects children in hospitals in Norway to see what makes some kids sicker than others and to understand the long-term effects of the virus.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 18 Years |
| Sex | All |
| Enrollment | 350 (estimated) |
| Sponsor | University Hospital, Akershus Academic / other |
| Locations | 1 site (Lørenskog) |
| Status | Recruiting |
| Started | April 3, 2020 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | February 16, 2022 |
| Trial ID | NCT04335773 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 0-18 years who are hospitalized with suspected COVID-19.
✕Probably not a fit
Patients over the age of 18 or those without suspected COVID-19 will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective cohort study examines COVID-19 infection among children in Norway, focusing on three main areas: epidemiological risk factors, the natural history of the disease including immunological responses, and long-term effects such as post-infectious fatigue. Children aged 0-18 years admitted to hospitals with suspected COVID-19 will be followed for six months, with those confirmed to have the virus serving as cases and those without as controls. The study aims to identify risk factors for severe outcomes, understand the immune response to the infection, and assess the prevalence of long-lasting complications.
Why it matters
Potential benefit: If successful, this study could enhance understanding of COVID-19 in children, leading to improved treatment and prevention strategies.
How similar studies have gone: Other studies have explored COVID-19 in pediatric populations, but this specific approach focusing on risk factors and long-term outcomes is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Suspected covid-19 infection and age 0-18 years Exclusion Criteria: Age \>18 years
Where it's running
-
Akershus universistetssykehus
Lørenskog, Norway Recruiting
Study contacts
- Study coordinator: Christopher Inchley, Phd
- Email: chris.inchley@gmail.com
- Phone: 90069276
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Persistent fatigue after infection: a look at why fatigue lingers
This observational study tests why persistent fatigue happens after infections like EBV and Long COVID, to understand the mechanisms in people who still feel tired weeks after symptoms begin.
-
Understanding and treating fatigue in primary care patients
This study is testing a new online therapy for fatigue to see if it helps people in primary care feel better compared to regular treatment.
-
Effects of suctioning on pain and stress in intubated ICU patients
This study is testing if suctioning the breathing tube in ICU patients causes more pain and stress compared to not suctioning.
-
Impact of e-cigarettes during pregnancy on children's health
This study looks at how using e-cigarettes during pregnancy affects the health of children in their early years.
-
Yoga vs Health Education for Persistent Post-COVID Fatigue
This trial will test whether adding a structured yoga program or health education to routine care helps reduce persistent fatigue in adults who had COVID-19.
-
Survey on COVID-19 impact in patients with primary immune deficiency
This study is trying to learn how COVID-19 has affected people with primary immune deficiencies to better understand their experiences and outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.